Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-San Kim

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
Cancer Letters|December 22, 2007
Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinaseSeung-Yoon Park, Wan Lee, Jaetae Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2021
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapyMinsu Kwon, Hanul Jung, Gi-Hoon Nam, et al.
Journal of Biochemistry|January 6, 2009
Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cellsYoichi Osada, Toshiro Sunatani, In-San Kim, et al.
Cancer Letters|July 6, 2020
Functionalized exosome harboring bioactive molecules for cancer therapyYoon Kyoung Kim, Yoonjeong Choi, Gi-Hoon Nam, et al.
Cancers|July 27, 2022
Cancer-Associated Fibroblasts in the Hypoxic Tumor MicroenvironmentIljin Kim, Sanga Choi, Seongkyeong Yoo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 24, 2025
Breaking barriers: Engineering extracellular vesicles for enhanced endosomal escape and therapeutic deliveryJihong Kim, Yeong Ha Hwang, Gi-Hoon Nam, et al.
Pharmaceutics|March 28, 2024
Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical ProgressJiyoung Goo, Yeji Lee, Jeongmin Lee, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effectsHye-Nam Son, Ju-Ock Nam, Soyoun Kim, et al.
Biochemical and Biophysical Research Communications|July 22, 2014
Myogenin is a positive regulator of MEGF10 expression in skeletal muscleSeung-Yoon Park, Youngeun Yun, Mi-Jin Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 27, 2025
Advances in transcription factor delivery: Target selection, engineering strategies, and delivery platformsYeji Lee, Seongkyeong Yoo, Seongeon Cho, et al.
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
Cancer Letters|December 22, 2007
Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinaseSeung-Yoon Park, Wan Lee, Jaetae Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2021
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapyMinsu Kwon, Hanul Jung, Gi-Hoon Nam, et al.
Journal of Biochemistry|January 6, 2009
Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cellsYoichi Osada, Toshiro Sunatani, In-San Kim, et al.
Cancer Letters|July 6, 2020
Functionalized exosome harboring bioactive molecules for cancer therapyYoon Kyoung Kim, Yoonjeong Choi, Gi-Hoon Nam, et al.
Cancers|July 27, 2022
Cancer-Associated Fibroblasts in the Hypoxic Tumor MicroenvironmentIljin Kim, Sanga Choi, Seongkyeong Yoo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 24, 2025
Breaking barriers: Engineering extracellular vesicles for enhanced endosomal escape and therapeutic deliveryJihong Kim, Yeong Ha Hwang, Gi-Hoon Nam, et al.
Pharmaceutics|March 28, 2024
Extracellular Vesicles in Therapeutics: A Comprehensive Review on Applications, Challenges, and Clinical ProgressJiyoung Goo, Yeji Lee, Jeongmin Lee, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effectsHye-Nam Son, Ju-Ock Nam, Soyoun Kim, et al.
Biochemical and Biophysical Research Communications|July 22, 2014
Myogenin is a positive regulator of MEGF10 expression in skeletal muscleSeung-Yoon Park, Youngeun Yun, Mi-Jin Kim, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 27, 2025
Advances in transcription factor delivery: Target selection, engineering strategies, and delivery platformsYeji Lee, Seongkyeong Yoo, Seongeon Cho, et al.
Pageof 30